Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Telikepalli, Srivalli N"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Telikepalli, Srivalli N., Kumru, Ozan S., Kalonia, Cavan, Esfandiary, Reza *, Joshi, Sangeeta B., Middaugh, C. Russell, Volkin, David B. *
Publikováno v:
In Journal of Pharmaceutical Sciences March 2014 103(3):796-809
Autor:
Telikepalli, Srivalli N., Carrier, Michael J., Ripple, Dean C., Barnett, Greg, Bhirde, Ashwinkumar, Bolton, Donna, Bou-Assaf, George M., Ferrari, Erica, Leigh, Scott, Levitskaya-Seaman, Sophia, Menzen, Tim, Nikels, Felix, Riley, Anna, Saggu, Miguel, Sahni, Neha, Vernooij, Eric, Wuchner, Klaus
Publikováno v:
AAPS PharmSciTech; Jan2023, Vol. 24 Issue 1, p1-12, 12p
Autor:
Naik, Subhashchandra, Kumru, Ozan S, Cullom, Melissa, Telikepalli, Srivalli N, Lindboe, Elizabeth, Roop, Taylor L, Joshi, Sangeeta B, Amin, Divya, Gao, Phillip, Middaugh, C Russell, Volkin, David B, Fisher, Mark T
The ability of a GroEL-based bio-layer interferometry (BLI) assay to detect structurally altered and/or aggregated species of pharmaceutically relevant proteins is demonstrated. Assay development included optimizing biotinylated-GroEL immobilization
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0087e423572a4c080557a00c3a65610f
https://europepmc.org/articles/PMC4287005/
https://europepmc.org/articles/PMC4287005/
Autor:
Telikepalli SN; NIST, Biomolecular Measurement Division, Maryland, Gaithersburg, USA. srivalli.telikepalli@nist.gov., Carrier MJ; NIST, Biomolecular Measurement Division, Maryland, Gaithersburg, USA., Ripple DC; NIST, Biomolecular Measurement Division, Maryland, Gaithersburg, USA., Barnett G; Currently at Lundbeck Seattle Biopharmaceuticals, Inc., Bothell, Washington, USA., Bhirde A; Food and Drug Administration, Office of Biotechnology Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, Silver Spring, Maryland, USA., Bolton D; Porton Biopharma Ltd., Salisbury, UK., Bou-Assaf GM; Biogen, Analytical Development, Cambridge, Massachusetts, USA., Ferrari E; Sanofi, BioAnalytics Germany, Characterization, Frankfurt Am Main, Germany., Leigh S; FibroGen, Inc., Analytical Development, San Francisco, California, USA., Levitskaya-Seaman S; MacroGenics, Inc., Analytical Sciences, BPD, Rockville, Maryland, USA., Menzen T; Coriolis Pharma Research Gmbh, Martinsried, Germany., Nikels F; Boehringer Ingelheim Pharma GmbH & Co., Innovation Unit, Biberach, KG, Germany., Riley A; Eli Lilly and Company, Global Quality Laboratories, Indianapolis, Indiana, USA., Saggu M; Genentech, Inc., Pharmaceutical Development, San Francisco, California, USA., Sahni N; Currently at MacroGenics, Drug Product Sciences, Drug Product Development, Rockville, Maryland, USA., Vernooij E; AstraZeneca, Global Operations Biologics, Nijmegen Manufacturing Facility, Nijmegen, Netherlands., Wuchner K; Janssen R&D, DPDS BTDS Analytical Development, Schaffhausen, Switzerland.
Publikováno v:
AAPS PharmSciTech [AAPS PharmSciTech] 2022 Dec 16; Vol. 24 (1), pp. 18. Date of Electronic Publication: 2022 Dec 16.
Autor:
Naik S; Department of Biochemistry and Molecular Biology, University of Kansas Medical Center, Kansas City, Kansas, 66160., Kumru OS, Cullom M, Telikepalli SN, Lindboe E, Roop TL, Joshi SB, Amin D, Gao P, Middaugh CR, Volkin DB, Fisher MT
Publikováno v:
Protein science : a publication of the Protein Society [Protein Sci] 2014 Oct; Vol. 23 (10), pp. 1461-78. Date of Electronic Publication: 2014 Jul 28.